Medicine | Oncology
Prostate cancer
Diagnosis
Clinical staging


Home > Disciplines > Medicine > Oncology > Prostate cancer > Diagnosis > Clinical staging


OVERVIEW


.

Abdel-Rahman O.
Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?
PLoS One. 2017 Nov 28;12(11):e0188450. doi: 10.1371/journal.pone.0188450. eCollection 2017.
Source | Full text | Similar articles



.

Telloni SM.
Tumor Staging and Grading: A Primer.
Methods Mol Biol. 2017 May 14;1606:1-17. doi: 10.1007/978-1-4939-6990-6_1.
Source | Full text | Similar articles



.

Varma M, Cochlin D, Delahunt B, Kynaston H, Rees J, Rous B, Narahari K.
TNM clinical staging of prostate cancer: Issues and solutions.
BJU Int. 2018 Oct 13. doi: 10.1111/bju.14589. [Epub ahead of print]
Source | Full text | Similar articles



.

Xiao WJ, Zhu Y, Zhu Y, Dai B, Ye DW.
Evaluation of clinical staging of the American Joint Committee on Cancer (eighth edition) for prostate cancer.
World J Urol. 2018 Jan 25. doi: 10.1007/s00345-018-2183-0. [Epub ahead of print]
Source | Full text | Similar articles



.

Xiao WJ, Zhu Y, Dai B, Ye DW.
Evaluation of the major changes in eighth edition of the American Joint Committee on Cancer pathological staging for prostate cancer treated with prostatectomy.
PLoS One. 2017 Nov 9;12(11):e0187887. doi: 10.1371/journal.pone.0187887. eCollection 2017.
Source | Full text | Similar articles



IMAGING FOR PREOPERATIVE STAGING AND RE-STAGING


.

Schiavina R, Chessa F, Borghesi M, Gaudiano C, Bianchi L, Corcioni B, Castellucci P, Ceci F, Ceravolo I, Barchetti G, Del Monte M, Campa R, Catalano C, Panebianco V, Nanni C, Fanti S, Minervini A, Porreca A, Brunocilla E.
State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer.
Int J Urol. 2018 Sep 20. doi: 10.1111/iju.13797. [Epub ahead of print]
Source | Full text | Similar articles



SUBCLASSIFICATION OF PT2 PCA IS NOT A PROGNOSTIC INDICATOR OF SURVIVAL-RELATED OUTCOMES AFTER RP.


.

Antunes HP, Parada B, Carvalho J, Eliseu M, Jarimba R, Oliveira R, Tavares-da-Silva E, Figueiredo A.
Prognostic value of subclassification (pT2 stage) of pathologically organ-confined prostate cancer: Confirmation of the changes introduced in the 8th edition of the American Joint Committee on Cancer (AJCC) staging system.
Arch Ital Urol Androl. 2018 Sep 30;90(3):191-194. doi: 10.4081/aiua.2018.3.191.
Source | Full text | Similar articles



.

Billis A, Freitas LLL, Costa LBE, Barreto IS, Magna LA, Matheus WE, Ferreira U.
The TNM 8th edition: Validation of the proposal for organ - confined (pT2) prostate cancer.
Int Braz J Urol. 2018 Nov 30;45. doi: 10.1590/S1677-5538.IBJU.2018.0338. [Epub ahead of print]
Source | Full text | Similar articles



.

Nguyen DP, Vertosick EA, Sharma V, Corradi RB, Vilaseca A, Takeda T, Sjoberg DD, Benfante N, Fine SW, Reuter VE, Scardino PT, Eastham JA, Karnes RJ, Touijer KA.
Does subclassification of pathologically organ-confined (pT2) prostate cancer provide prognostic discrimination of outcomes after radical prostatectomy?
J Urol. 2018 Jan 4. pii: S0022-5347(18)30005-3. doi: 10.1016/j.juro.2017.12.056. [Epub ahead of print]
Source | Full text | Similar articles



T-STAGING


(Definitions)
(DRE, PSA level and biopsy findings)
(Transrectal ultrasound (TRUS))
(Multiparametric magnetic resonance imaging (MRI))




N-STAGING


(PSA level and biopsy findings)


.

Shinde A, Li R, Glaser S, Amini A.
Node-positive Nonmetastatic Prostate Cancer: Time to Reconsider Prognostic Staging?
Eur Urol. 2018 Sep 24. pii: S0302-2838(18)30667-5. doi: 10.1016/j.eururo.2018.09.017. [Epub ahead of print]
Source | Full text | Similar articles



NODAL STAGING USING CT AND MRI


.

Kilcoyne A, Price MC, McDermott S, Harisinghani MG.
Imaging on nodal staging of prostate cancer.
Future Oncol. 2016 Oct 27. [Epub ahead of print]
Source | Full text | Similar articles



.

von Below C, Daouacher G, Wassberg C, Grzegorek R, Gestblom C, Sörensen J, Ahlström H, Waldén M.
Validation of 3 T MRI including diffusion-weighted imaging for nodal staging of newly diagnosed intermediate- and high-risk prostate cancer.
Clin Radiol. 2016 Jan 13. pii: S0009-9260(15)00484-5. doi: 10.1016/j.crad.2015.12.001. [Epub ahead of print]
Source | Full text | Similar articles



(Lymphadenectomy)




M-STAGING


(Alkaline phosphatase)




BONE SCAN


.

Freedland SJ, Howard LE, Hanyok BT, Kadiyala VK, Kuang JY, Whitney CA, Wilks FR, Kane CJ, Terris MK, Amling CL, Cooperberg MR, Aronson WJ, Moreira DM.
Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer.
BJU Int. 2016 Jan 13. doi: 10.1111/bju.13405. [Epub ahead of print]
Source | Full text | Similar articles



NEW IMAGING MODALITIES
(Nodal metastases)
(Bone metastasis)




68Ga-PSMA


.

van Leeuwen PJ, Stricker P, Hruby G, Kneebone A, Ting F, Thompson B, Nguyen Q, Ho B, Emmett L.
68Ga-PSMA has high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.
BJU Int. 2015 Dec 18. doi: 10.1111/bju.13397. [Epub ahead of print]
Source | Full text | Similar articles